0.43

19.66% -0.1052

Estrella Immunopharma Inc (ESLA)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$0.5352

Offen:

$0.4952

24-Stunden-Volumen:

4.23M

Relative Volume:

0.48

Marktkapitalisierung:

$18.70M

Einnahmen:

Nettoeinkommen (Verlust:

$-13.25M

KGV:

-1.2171

EPS:

-0.3533

Netto-Cashflow:

$-8.02M

1W Leistung:

+4.88%

1M Leistung:

-32.80%

6M Leistung:

-74.10%

1J Leistung:

-73.30%

1-Tages-Spanne:

$0.4208

$0.51

1-Wochen-Bereich:

$0.295

$0.85

52-Wochen-Spanne:

$0.295

$3.15

Estrella Immunopharma Inc Stock (ESLA) Company Profile

Firmenname

Estrella Immunopharma Inc

Sektor

Healthcare (1052)

Branche

Biotechnology (594)

Telefon

(510) 318-9098

Adresse

5858 HORTON STREET, SUITE 370, EMERYVILLE

Mitarbeiter

Twitter

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

ESLA's Discussions on Twitter

Compare ESLA vs VRTX, MRNA, REGN, ARGX, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ESLA Estrella Immunopharma Inc	0.43	18.70M	0	-13.25M	-8.02M	-0.3533
VRTX Vertex Pharmaceuticals Inc	499.74	126.66B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	218.01	87.04B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	790.74	81.41B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	819.14	51.51B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	369.06	41.75B	5.76B	514.49M	1.10B	4.4813

Estrella Immunopharma Inc Aktie (ESLA) Neueste Nachrichten

Oct 15, 2026

A director receives 2,037 shares instead of cash at Hyperliquid Strategies (PURR). - Stock Titan

Oct 15, 2026

Stock replaces cash pay for a Hyperliquid Strategies (PURR) director, who acquires 3,056 shares. - Stock Titan

Oct 15, 2026

Shares replace cash pay for Hyperliquid Strategies (PURR) director in 1,358-share award - Stock Titan

Oct 15, 2026

Oct 14, 2026

A 15,000-share sale is proposed by Cloudastructure (CSAI) founder Sheldon Richard Bentley. - Stock Titan

Oct 14, 2026

Oct 10, 2026

ESLA 10-K/A & SEC Filings - Yahoo! Finance Canada

Oct 10, 2026

Oct 09, 2026

A director received 21,154 stock units at WRAP Technologies (WRAP); 13,750 vested on October 1. - Stock Titan

Oct 09, 2026

Oct 05, 2026

Director John Burgess exercises 5,000 Taylor Devices (TAYD) options at $13.80 each. - Stock Titan

Oct 05, 2026

Oct 02, 2026

After a 213-share grant, ChoiceOne (COFS) director Curt E. Coulter holds 11,365 shares directly. - Stock Titan

Oct 02, 2026

AT&T (T) CFO acquires 1,836 stock units through payroll deductions and partial company matching. - Stock Titan

Oct 02, 2026

Oct 01, 2026

Three monthly payments go to ARMOUR's preferred shareholders through December. - Stock Titan

Oct 01, 2026

Sep 24, 2026

Across three days, DSS sold 906 Impact Biomedical (IBO) shares at prices from $0.55 to $7.0587. - Stock Titan

Sep 24, 2026

Sep 20, 2026

Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightChaikin Flow - dars.gov.et

Sep 20, 2026

Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightAI Trade Signals - dars.gov.et

Sep 20, 2026

Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightHigh Dividend Factor - dars.gov.et

Sep 20, 2026

Sep 15, 2026

Rule 10b5-1 stock sale by F5 (FFIV) marketing chief - Stock Titan

Sep 15, 2026

Sep 08, 2026

Estrella Immunopharma Faces Nasdaq Listing Compliance Challenge - TipRanks

Sep 08, 2026

Estrella Immunopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Sep 08, 2026

Sep 03, 2026

Intercontinental Exchange (NYSE: ICE) officer sells 5,000 shares under trading plan - Stock Titan

Sep 03, 2026

Sep 02, 2026

MiNK Therapeutics (INKT) insider reports stock trades - Stock Titan

Sep 02, 2026

Aug 31, 2026

QT Imaging (QTI) awards its CEO 484K RSUs that vest through 2030, with all shares accelerating if the company undergoes a change of control. - Stock Titan

Aug 31, 2026

Aug 25, 2026

Greif shareholders will receive $0.62 or $0.93 per share on Oct. 1 - Stock Titan

Aug 25, 2026

Apollo Commercial (NYSE: ARI) director plans 960-share family sale - Stock Titan

Aug 25, 2026

Aug 21, 2026

Estrella Immunopharma Receives Nasdaq Minimum Bid Price Notice - TipRanks

Aug 21, 2026

Estrella Immunopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Aug 21, 2026

Aug 20, 2026

ARMISTICE CAPITAL, LLC Reduces Stake in Estrella Immunopharma Inc (ESLA) by Nearly Half - GuruFocus

Aug 20, 2026

Aug 19, 2026

PriceSmart (NASDAQ: PSMT) executive sells 338 shares at $177.87 - Stock Titan

Aug 19, 2026

Aug 16, 2026

Estrella Immunopharma (ESLA) Holds Ground at $0.72 as Immunotherapy Pipeline Takes Center StageLong Short Pair - vinanet.vn

Aug 16, 2026

Price to earnings forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView

Aug 16, 2026

Estrella Immunopharma (ESLA) Holds Ground at $0.72 as Immunotherapy Pipeline Takes Center StageLow Risk Entry Stocks - dars.gov.et

Aug 16, 2026

Aug 15, 2026

Estrella Immunopharma (ESLA) Holds at $0.72 as Support Firms in Quiet Micro-Cap SessionIchimoku TK Cross - vinanet.vn

Aug 15, 2026

ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignInstitutional Buy Signals - vinanet.vn

Aug 15, 2026

ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignTriangle Correction - siam.in

Aug 15, 2026

ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignScalping Stock Signals - dars.gov.et

Aug 15, 2026

Estrella Immunopharma (ESLA) Holds at $0.72 as Support Firms in Quiet Micro-Cap SessionFactor Rotation - dars.gov.et

Aug 15, 2026

Estrella Immunopharma Inc. (NASDAQ: ESLA) Share Price, ESLA Stock News, ESLA Share Price & Updates - kalkine.com.au

Aug 15, 2026

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatSystematic Flow - vinanet.vn

Aug 14, 2026

Estrella Immunopharma (ESLA): Armistice Capital discloses 4.99% ownership stake - Stock Titan

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatPost-Earnings Moves - dars.gov.et

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatFibonacci Fan - dars.gov.et

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatSingle Stock ETF - dars.gov.et

Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatLow Risk Entry Stocks - dars.gov.et

Aug 14, 2026

Aug 13, 2026

Estrella Immunopharma, Inc. 2Q 2026: Net loss $(2.31M), EPS $(0.05) — 10-Q Summary - TradingView

Aug 13, 2026

Tranche Update on Estrella Immunopharma, Inc.'s Equity Buyback Plan announced on January 30, 2024. - marketscreener.com

Aug 13, 2026

Aug 11, 2026

Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace

Aug 11, 2026

Estrella adds fourth site to EB103 lymphoma trial - Investing.com

Aug 11, 2026

Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Yahoo Finance

Aug 11, 2026

Aug 08, 2026